Patients with melanoma metastases at cutaneous and subcutaneous sites are highly susceptible to interleukin-2-based therapy
(Q73519509)
scientific article published on 01 January 2001
scientific article published on 01 January 2001
Language:
Current Data About
Patients with melanoma metastases at cutaneous and subcutaneous sites are highly susceptible to interleukin-2-based therapy
other details
| description | scientific article published on 01 January 2001 |
External Links
| (P356) |
10.1097/00002371-200101000-00010
|
| (P698) |
11211152
|